Compare ARK Genomic Revolution ETF (ARKG) vs Salesforce Inc (CRM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Salesforce Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Salesforce Inc trades at $164.58 (market cap $133.76B). The key difference: Salesforce Inc pays a 1.08% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Salesforce Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | CRM | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $270.25 |
52-Week Low | $23.09 | $150.12 |
Market Cap | — | $133.76B |
Enterprise Value | — | $163.81B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Salesforce (CRM) trades at $163.32, up 0.5% with a bearish technical signal despite strong fundamentals. The company reported consistent earnings beats with Q1 2026 EPS of $3.88 versus $3.13 expected, maintaining robust profitability with 77.64% gross margins and 18.73% net income margin. Recent news highlights AI-driven growth potential but also sector-wide software stock pressures.
Outlook remains positive with analyst consensus target of $235.20 (44% upside), though technical weakness and competitive AI threats pose near-term risks. Revenue growth trajectory and expanding cash flow support long-term value, but investors should monitor sector volatility and execution on AI monetization.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →
